Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma

详细信息    查看全文

• 作者：Anupam Dutta (1)
  Nabajyoti Saikia (2)
  Jyotirmoy Phookan (3)
  Munindra Narayan Baruah (4)
  Shashi Baruah (1)
  
• 关键词：Family history of cancer ; Human leukocyte antigen ; Killer cell immunoglobulin ; like receptors ; Oral squamous cell carcinoma ; Tibeto ; Burman
• 刊名：Immunogenetics
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：66
• 期：7-8
• 页码：439-448
• 全文大小：446 KB
• 参考文献：1. Al Omar YS, Marshall E, Middleton D, Christmas SE (2011) Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer. Immunology 133:94鈥?04 CrossRef
  2. Ashouri E, Ghaderi A, Reed EF, Rajalingam R (2009) A novel duplex SSP鈥揚CR typing method for KIR gene profiling. Tissue Antigens 74:62鈥?7 CrossRef
  3. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. International Agency for Research on Cancer Publications, Lyon
  4. Bashirova AA, Martin MP, McVicar DW, Carrington M (2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7:277鈥?00 CrossRef
  5. Boyton RJ, Altmann DM (2007) Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 149:1鈥? CrossRef
  6. Campillo JA, Legaz I, Alvarez MRL, Bolarin JM, Heras BL, Muro M et al (2013) KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis. Immunogenetics 65:333鈥?43 CrossRef
  7. Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P et al (2013) HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Clin Cancer Res 19:5465鈥?473 CrossRef
  8. Carrington M, Norman P (2003) The KIR gene cluster. National Library of Medicine (US), National Center for Biotechnology Information, Bethesda
  9. Cereb N, Maye P, Lee S, Kong Y, Yang SY (1995) Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, HLA-B, and HLA-C alleles. Tissue Antigens 45:1鈥?1 CrossRef
  10. Du Z, Gjertson DW, Reed EF, Rajalingam R (2007) Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59:1鈥?5 CrossRef
  11. Dutta A, Lourembam SD, Pradhan S, Baruah S (2013) KIR diversity in three ethnic populations of Assam state, Northeast India. Tissue Antigens 82:48鈥?2 CrossRef
  12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. American Joint Committee on Cancer, Chicago
  13. Guerini FR, Mancuso R, Agostini S, Agliardi C, Zanzottera M, Hernis A et al (2012) Activating KIR/HLA complexes in classic Kaposi鈥檚 sarcoma. Infect Agents Cancer 7:9 CrossRef
  14. Hirayasu K, Ohashi J, Kashiwase K, Hananantachai H, Naka I, Ogawa A et al (2012) Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog 8:e1002565 CrossRef
  15. Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T et al (2009) Susceptibility to Crohn 鈥檚 disease is mediated by KIR 2DL2 / KIR 2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 61:663鈥?71 CrossRef
  16. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E et al (2005) Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 33:e56 CrossRef
  17. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J et al (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872鈥?74 CrossRef
  18. Koehler RN, Walsh AM, Moqueet N, Currier JR, Eller MA, Eller LA et al (2009) High-through put genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR. Tissue Antigens 74:73鈥?0 CrossRef
  19. Kovacic MB, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ et al (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14:2673鈥?677 CrossRef
  20. Kulkarnia S, Martin MP, Carrington M (2008) The ying and yang of HLA and KIR in human disease. Semin Immunol 20:343鈥?52 CrossRef
  21. Kusnierczyk P (2013) Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol 4:8 CrossRef
  22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2^-鈭嗏垎C _T method. Methods 25:402鈥?08 CrossRef
  23. Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE (2006) CD94/NKG2A Inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol 177:3590鈥?596 CrossRef
  24. Moesta AK, Parham P (2012) Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol 3:336 CrossRef
  25. Nemesure B, Wu SY, Hennis A, Leske MC (2013) Family history of prostate cancer in a Black population. J Immigr Minor Health 15:1107鈥?112 CrossRef
  26. Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin H et al (2011) KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS One 6:e25682 CrossRef
  27. Pan N, Qiu J, Sun H, Miao F, Shi Q, Xu J, et al. (2013) Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection. Clin. Dev. Immunol. 7 pages
  28. Parham P, Moffett A (2013) Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13:133鈥?44 CrossRef
  29. Parham P, Norman PJ, Rached LA, Guethlein LA (2012) Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Phil Trans R Soc B 367:800鈥?11 CrossRef
  30. Purdy AK, Campbell KS (2009) Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther 8:13鈥?2 CrossRef
  
• 作者单位：Anupam Dutta (1)
  Nabajyoti Saikia (2)
  Jyotirmoy Phookan (3)
  Munindra Narayan Baruah (4)
  Shashi Baruah (1)
  
  1. Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, Tezpur, 784028, Assam, India
  2. Departments of E.N.T., Assam Medical College and Hospital, Dibrugarh, 786001, Assam, India
  3. Department of E.N.T., Gauhati Medical College and Hospital, Guwahati, 781032, Assam, India
  4. Department of E.N.T., North East Cancer Hospital and Research Institute, 11th Mile, Amerigog, Jorabat, Guwahati, 781023, Assam, India
  
• ISSN：1432-1211

文摘

Killer cell immunoglobulin-like receptors (KIR) are involved in regulating natural killer cell activation through recognition of their human leukocyte antigen (HLA) class I ligands. We conducted a case-control study with 169 oral squamous cell carcinoma (OSCC) patients and 177 healthy participants to study the genomic diversity of KIR and HLA loci and KIR gene expression in context of family history of cancer (FHC) in OSCC. Polymerase chain reaction (PCR) sequence-specific priming approach was used to type 16 KIR genes in individuals. SSP-real-time PCR was used for HLA class I ligand genotyping and real-time quantitative reverse transcriptase PCR was used to determine the expression of KIR gene. KIR2DL1+-HLA-C2+ genotype was higher and positively associated with OSCC. Notably, all KIR2DL1+-HLA-C2+ genotypes occurred exclusively in patients with FHC, showing a strong positive association of KIR2DL1+-HLA-C2+ genotype with FHC. In addition, all younger age group patients (+-HLA-C2+ genotype suggesting association of the genotype with early onset of disease. RNA transcript abundance of inhibitory KIR2DL1 in FHC patients, particularly of lower age groups (+-HLA-C+ genotype was negatively associated with OSCC. Our findings suggest KIR2DL1+-HLA-C2+ genotype as heritable risk factor in OSCC predisposing to OSCC at younger age. Interestingly, KIR2DL3+-HLA-C+ genotype was seen to be protective in OSCC. This study may be useful towards cancer surveillance and early detection of oral cancer in patients with FHC.